Kaufmann S H, Gores G J
Division of Oncology Research and Department of Molecular Pharmacology, Mayo Graduate School, Rochester, Minnesota, USA.
Bioessays. 2000 Nov;22(11):1007-17. doi: 10.1002/1521-1878(200011)22:11<1007::AID-BIES7>3.0.CO;2-4.
The accumulation of neoplastic cells can occur through enhanced proliferation, diminished cell turnover, or a combination of both processes. Although the potential contribution of diminished cell turnover to tumor development has been appreciated for a decade, more recent studies in animal models and clinical cancer specimens have elucidated the mechanisms by which alterations in the apoptotic machinery contribute to the process of carcinogenesis. At the same time, a different group of studies have demonstrated the feasibility of eliminating neoplastic cells by selectively inducing apoptosis. In this essay, we review recent developments in the fields of carcinogenesis and molecular therapeutics in light of new understanding of apoptotic pathways.
肿瘤细胞的积累可通过增殖增强、细胞更新减少或这两个过程的组合而发生。尽管细胞更新减少对肿瘤发展的潜在作用在十年前就已得到认识,但最近在动物模型和临床癌症标本中的研究阐明了凋亡机制的改变促进致癌过程的机制。与此同时,另一组研究证明了通过选择性诱导凋亡来消除肿瘤细胞的可行性。在本文中,我们根据对凋亡途径的新认识,综述了致癌作用和分子治疗领域的最新进展。